In endometrial carcinoma, the mutation frequencies were 3.3% for SMYD1, 2.1% for SMYD2, 2.1% for SMYD3, 2.1% for SMYD4, and 2.4% for SMYD5. This evidence concerns the gene SMYD4 and endometrial carcinoma.